Skip to main content
. 2023 Aug 31;39(4):648–658. doi: 10.1093/ndt/gfad189

Table 1:

Percentage of recipients aged 65 years or older, percentage female and percentage with DM as PRD with corresponding APC between 2010 and 2019 for total, DD and LD first kidney transplantation, by country.

Percentage aged 65 years or older Percentage female Percentage with DM as PRD
Cohort Cohort APC 2010–19 Cohort Cohort APC 2010–19 Cohort Cohort APC 2010–19
2010–14 2015–19 (95% CI) 2010–14 2015–19 (95% CI) 2010–14 2015–19 (95% CI)
Total
 ALL 20.7 25.2 4.5 (3.8 to 5.2) 36.7 36.1 –0.3 (–0.6 to 0.0) 15.0 15.7 1.0 (0.3 to 1.7)
 AT 23.9 23.6 –1.0 (–3.2 to 1.3) 33.9 31.6 –1.3 (–3.9 to 1.4) 16.6 14.2 –5.2 (–9.6 to –0.6)
 BA 0.0 1.8 NA 35.6 33.3 0.3 (–11.6 to 13.8) 7.8 6.3 NA
 BE 19.4 21.6 1.7 (0.1 to 3.4) 37.1 34.3 –0.5 (–2.8 to 1.8) 12.1 13.8 0.6 (–3.4 to 4.7)
 DK 13.2 18.7 8.0 (3.6 to 12.6) 38.7 34.6 –1.3 (–4.9 to 2.5) 15.1 15.9 –0.6 (–4.4 to 3.4)
 ES 23.9 31.5 5.3 (4.1 to 6.5) 35.5 34.9 –0.5 (–1.0 to 0.0) 15.4 16.0 0.9 (–0.6 to 2.4)
 FI 21.8 23.0 1.4 (–3.2 to 6.3) 32.6 34.9 1.5 (–1.8 to 5.0) 31.1 27.2 –1.6 (–3.3 to 0.1)
 FR 22.0 26.4 5.3 (3.2 to 7.5) 37.0 36.4 –0.6 (–1.4 to 0.3) 13.5 14.0 0.8 (–0.4 to 2.2)
 GR 8.8 8.0 0.5 (–8.9 to 11.0) 34.3 32.7 –0.1 (–3.9 to 3.8) 5.9 6.0 –0.9 (–10.6 to 9.8)
 NL 23.7 30.5 5.3 (3.9 to 6.7) 38.4 38.2 –0.1 (–1.7 to 1.6) 13.9 14.3 1.7 (–0.5 to 4.0)
 NO 29.4 29.5 0.8 (–1.0 to 2.7) 30.0 36.0 2.6 (–1.6 to 6.9) 18.1 15.8 –2.0 (–5.2 to 1.2)
 SE 19.6 22.6 3.9 (0.4 to 7.5) 36.3 33.0 –1.2 (–3.6 to 1.3) 17.4 16.3 –1.6 (–4.1 to 0.9)
 UK 16.0 19.1 4.2 (3.1 to 5.4) 38.0 37.9 0.0 (–0.6 to 0.6) 15.8 17.7 2.7 (1.3 to 4.1)
Deceased donor
 ALL 23.6 28.1 4.1 (3.2 to 4.9) 36.4 36.1 –0.3 (–0.7 to 0.2) 17.1 17.8 1.0 (0.3 to 1.7)
 AT 27.0 26.7 –0.8 (–3.0 to 1.4) 34.7 32.1 –1.5 (–4.3 to 1.5) 18.9 16.2 –5.1 (–9.6 to –0.3)
 BA 0.0 3.3 N.A. 25.9 43.3 –26.7 (–59.8 to 33.4) 14.8 6.7 N.A.
 BE 20.8 23.3 1.7 (–0.2 to 3.7) 36.9 34.2 –0.5 (–2.8 to 1.9) 13.1 14.6 0.3 (–3.4 to 4.1)
 DK 15.7 23.2 7.7 (2.0 to 13.7) 40.2 36.4 –0.5 (–3.5 to 2.5) 15.5 17.2 –0.7 (–7.0 to 6.1)
 ES 26.3 33.8 4.8 (3.6 to 6.0) 35.0 34.7 –0.4 (–1.0 to 0.3) 16.7 17.3 0.8 (–0.6 to 2.3)
 FI 22.4 24.7 2.0 (–2.4 to 6.6) 33.0 34.4 1.2 (–2.2 to 4.7) 31.8 28.9 –0.9 (–2.8 to 1.0)
 FR 23.9 28.5 5.1 (2.8 to 7.5) 37.4 36.8 –0.6 (–1.4 to 0.3) 14.5 15.2 1.1 (–0.1 to 2.4)
 GR 10.8 10.5 1.6 (–9.8 to 14.4) 35.1 35.5 0.4 (–4.0 to 5.0) 5.6 6.3 –4.7 (–24.5 to 20.2)
 NL 30.7 39.4 6.4 (2.4 to 10.7) 36.9 38.0 –0.1 (–2.1 to 2.0) 19.5 22.1 3.0 (1.2 to 4.9)
 NO 33.8 31.9 –0.4 (–2.0 to 1.2) 29.7 38.5 4.3 (–0.1 to 8.9) 21.5 18.4 –2.4 (–5.4 to 0.8)
 SE 24.4 28.0 3.4 (–0.1 to 7.0) 37.9 33.7 –1.9 (–4.6 to 0.8) 22.0 19.4 –1.9 (–3.5 to –0.2)
 UK 18.9 21.3 3.2 (1.8 to 4.6) 37.2 37.3 0.2 (–0.6 to 1.0) 19.4 21.1 2.2 (0.6 to 3.7)
Living donor
 ALL 11.2 14.9 6.4 (5.2 to 7.6) 37.6 36.2 –0.5 (–1.2 to 0.2) 8.3 8.2 –0.7 (–3.2 to 1.9)
 AT 8.0 9.0 11.3 (–23.8 to 62.7) 29.9 29.2 –0.1 (–5.4 to 5.6) 4.8 4.7 –4.5 (–14.1 to 6.2)
 BA 0.0 1.2 >NA 38.7 29.6 1.7 (–12.6 to 18.3) 4.8 6.2 NA
 BE 5.3 6.9 23.4 (–22.1 to 95.6) 38.9 36.5 –0.7 (–3.9 to 2.7) 2.6 6.9 11.2 (–4.3 to 29.3)
 DK 9.9 10.9 6.0 (–4.9 to 18.1) 36.7 31.3 –3.7 (–6.4 to –1.0) 14.4 13.5 –1.2 (–6.4 to 4.4)
 ES 8.8 12.5 9.3 (5.3 to 13.4) 39.1 36.2 –0.6 (–2.8 to 1.6) 7.3 6.2 –3.5 (–10.4 to 4.0)
 FI 5.4 6.1 >NA 24.3 39.0 10.1 (–0.6 to 22.1) 16.2 6.1 >NA
 FR 8.3 15.1 15.4 (11.2 to 19.9) 33.7 34.0 –0.1 (–1.3 to 1.2) 6.0 8.0 2.5 (–3.7 to 9.1)
 GR 4.2 4.7 –0.4 (–36.8 to 57.1) 32.5 28.8 –0.9 (–5.1 to 3.5) 6.6 5.5 –2.7 (–19.3 to 17.4)
 NL 17.5 23.1 5.4 (3.0 to 7.9) 39.8 38.4 –0.1 (–2.1 to 1.9) 8.9 7.8 –0.5 (–4.8 to 4.1)
 NO 16.6 22.3 6.8 (1.4 to 12.6) 31.1 28.5 –2.4 (–7.7 to 3.1) 8.1 8.1 1.4 (–12.5 to 17.5)
 SE 12.1 9.4 –1.6 (–9.1 to 6.5) 34.0 31.2 –0.3 (–3.6 to 3.2) 10.2 8.8 –4.9 (–15.1 to 6.5)
 UK 10.5 13.6 5.4 (3.6 to 7.2) 39.4 39.2 –0.3 (–1.8 to 1.3) 8.9 9.1 0.6 (–2.0 to 3.2)

APCs were calculated using the percentages from each year. NA, not available. Arrows indicate statistically significant trends.